ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1306

Clinical and Imaging Characteristics of Spondyloarthritis Among Crohn’s Disease Patients

Laarni Quimson1, Nisa Oren2, Catherine Burns3 and Reem Jan2, 1University of Chicago, Oak Park, IL, 2University of Chicago, Chicago, IL, 3Indiana University, Indianapolis, IN

Meeting: ACR Convergence 2021

Keywords: Ankylosing spondylitis (AS), Back pain, Imaging, spondyloarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 8, 2021

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes III: Comorbidities, Extra-muskuloskeletal Manifestations, & Related Conditions (1304–1328)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Inflammatory bowel disease (IBD) affects up to 1.3% of the population and is associated with musculoskeletal manifestations including spondyloarthritis (SpA). Axial SpA (axSpA) is estimated to occur in 3-10% of IBD patients, but variation in imaging modalities and diagnostic criteria may underestimate the prevalence. Early recognition and identification of inflammatory changes on imaging can influence treatment that can alleviate symptoms, prevent radiographic progression, and improve quality of life. The aim of this study is to determine the prevalence of inflammatory changes on imaging in the Crohn’s disease (CD) population utilizing routine magnetic resonance enterography (MRE) or magnetic resonance imaging (MRI) and to identify patient characteristics that can assist in early recognition of axSpA.

Methods: This is a retrospective chart review of patients with a diagnosis of CD at our institution between 2014 and 2020. Inclusion criteria included patients with CD, 18 years of age or older, with MRE or MRI pelvis studies available for review. Exclusion criteria included patients with ulcerative colitis, less than 18 years of age, and those without imaging. Images were reviewed by a blinded radiologist using the Assessment of Spondyloarthritis international Society criteria including abnormal enhancement on T1- weighted fat-saturated images and bone marrow edema on T2-weighted fat-saturated images as well as inflammatory structural lesions such as fat deposits, erosions, sclerosis, or ankylosis. Demographics, medical history, medications, and labs at the time of imaging were recorded. Patients were assessed by a questionnaire for rheumatologic symptoms including inflammatory back pain and peripheral joint manifestations.

Results: 48 patients met the inclusion criteria. 41 had MREs and 7 had MRIs of the pelvis. 12 patients (25%) were identified with imaging abnormalities, all of which were found on MREs. 7 had structural lesions indicating prior inflammation and 5 were noted to have abnormal enhancement or bone marrow edema in the sacroiliac joints. From the 12 patients with imaging abnormalities, 8 (67%) were asymptomatic with no reported back pain or stiffness, 9 (75%) were female, 8 (67%) had stricturing or penetrating CD (Table). 3 patients (25%) were seeing a rheumatologist. From all the patients surveyed, 13 (30%) reported back pain, 26 (59%) reported previous joint pain or swelling, 13 (30%) had previous entire digit swelling, and 16 (36%) reported previous heel pain.

Conclusion: This study reveals that among Crohn’s disease patients at our institution, the prevalence of abnormal sacroiliac joint findings on MRE and MRI is 25%. Majority of these patients did not report back pain, were female, and had intestinal complications of CD. Only 25% were following with a rheumatologist. Asymptomatic or subclinical axSpA in Crohn’s disease patients remains under diagnosed and our study suggests that MREs should be routinely evaluated for musculoskeletal abnormalities. Furthermore, female sex and sticturing or penetrating CD may be risk factors for axSpA. Patients with these characteristics should be formally evaluated for the presence of inflammatory back pain as part of their clinical care.

Table. Patient characteristics and medical history. BMI: Body mass index; CD: Crohn’s Disease; B1p: nonstricturing perianal disease; B2p: stricturing perianal disease; B3p: penetrating perianal disease


Disclosures: L. Quimson, None; N. Oren, None; C. Burns, None; R. Jan, None.

To cite this abstract in AMA style:

Quimson L, Oren N, Burns C, Jan R. Clinical and Imaging Characteristics of Spondyloarthritis Among Crohn’s Disease Patients [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/clinical-and-imaging-characteristics-of-spondyloarthritis-among-crohns-disease-patients/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-and-imaging-characteristics-of-spondyloarthritis-among-crohns-disease-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology